May 19, 2022
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Abby Adams
| Re: | Angion Biomedica Corp. |
Registration Statement on Form S-3
File No. 333-264994
Acceleration Request
Requested Date: May 23, 2022
Requested Time: 4:00 PM Eastern Daylight Time
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the Registration Statement on Form S-3 (File No. 333-264994) (the “Registration Statement”) to become effective on Monday, May 23, 2022 at 4:00 p.m. Eastern Daylight Time, or as soon as practicable thereafter, or at such later time as the Registrant may orally request via telephone call to the staff of the Commission (the “Staff”). The Registrant hereby authorizes Kenneth Guernsey of Cooley LLP, counsel to the Registrant, to make such request on its behalf.
Once the Registration Statement has been declared effective, please orally confirm that event with Kenneth Guernsey of Cooley LLP, counsel to the Registrant, at (650) 693-2091.
| Very truly yours, | ||
| Angion Biomedica Corp. | ||
| By: | /s/ Jennifer J. Rhodes | |
| Jennifer J. Rhodes | ||
| General Counsel | ||
| cc: | Kenneth Guernsey, Cooley LLP |
